ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bile duct cancer: drug combo shows promise in late-stage trial
Disease control OngoingThis study tests a combination of three drugs (fluorouracil, leucovorin, and nanoliposomal irinotecan) in people with advanced biliary tract cancer whose disease has worsened after standard chemotherapy. The goal is to see if this treatment can stop the cancer from growing for at…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Immunotherapy duo takes on rare cancers in new trial
Disease control OngoingThis study tests whether combining two immunotherapy drugs, ipilimumab and nivolumab, can shrink or control rare cancers that have not responded to other treatments. The trial includes 240 adults with advanced biliary tract, neuroendocrine, gynecologic, or MSI-H solid tumors. Res…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control OngoingThis study tests whether combining two drugs, regorafenib and durvalumab, can help people with advanced biliary tract cancer that has stopped responding to chemotherapy. About 40 participants will receive the treatment to see if it shrinks tumors or slows disease progression. The…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New drug combo shows promise for tough bile duct cancer
Disease control OngoingThis study tests a combination of two drugs, lenvatinib and paclitaxel, in people with advanced bile duct cancer that has stopped responding to standard chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. About 51 adults with various types of…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated May 18, 2026 12:00 UTC